NCT02815891

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 15,000 (estimated)
• Sponsor: Target PharmaSolutions, Inc. · Industry
• Sex: All
• Age: 2 Years
• Healthy volunteers: Not accepted

Summary

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.

Conditions

• Nonalcoholic Fatty Liver
• Nonalcoholic Steatohepatitis

Timeline

• Start date: 2016-07-01
• Primary completion: 2036-07-01
• Completion: 2036-07-01
• First posted: 2016-06-28
• Last updated: 2026-03-27

Locations

74 sites across 3 countries: United States, Germany, Spain